Western medicinal composition for treating acute or chronic dyspnea and preparation method of western medicinal composition

Abstract

The invention relates to a western medicinal composition for treating acute or chronic dyspnea and a preparation method of the western medicinal composition. The western medicinal composition for treating the acute or chronic dyspnea is formed by grinding and mixing racanisodamine hydrochloride, ephedrine hydrochloride and dioxopromethazine hydrochloride. The western medicinal composition and the preparation method thereof disclosed by the invention have the beneficial effects that the western medicinal composition for treating the acute or chronic dyspnea is mainly used for improving or removing the dyspnea generated by respiratory system dysfunction, and plays biphasic effects of inhibiting excessiveness and insufficient activation aiming at unbalanced inflammatory response of the whole body, so that a dysfunction mechanism restores to a regular dynamic balance. The western medicinal composition disclosed by the invention belongs to a medicine which takes effect for pathogenesis of the whole body inflammatory response disorder caused by multiple acute or chronic infectious and noninfectious diseases, in particular to lung dysfunction.

Description

technical field [0001] The invention belongs to the field of medicines, and in particular relates to a western medicine composition for treating acute and chronic dyspnea and a preparation method thereof. Background technique [0002] At present, the acute exacerbation of COPD patients is inseparable from oxygen infusion and aerosol inhalation containing glucocorticoids, which cannot solve the problem of structural dysfunction of alveolar elastic fiber contraction weakness and poor domination of external respiratory muscles. Respiratory distress in acute viral severe pneumonia is mainly due to the cascade effect of uncontrolled inflammatory cytokines, which manifests as congestion and edema of lung tissue, and if the treatment is not effective, alveolar collapse will result in hemorrhage. The existing treatment methods are anti-virus, anti-shock, nutritional supplementation or positive end-expiratory pressure oxygen delivery, but they cannot solve the fundamental cause of th...

AI Technical Summary

Problems solved by technology

The existing treatment methods are anti-virus, anti-shock, nutritional supplementation or positive end-expiratory pressure oxygen delivery, but they cannot solve the fundamental cause of the patient's immune imbalance. Hematopoietic function is also inhibited, and progenitor cells and stem cells cannot differentiate in time to transport the cells that the body urgently needs to replenish, which is also the main reason why severe influenza pneumonia is difficult to treat

[0003] Pneumoconiosis combined with pulmonary fibrosis is still a medical problem in the world. In recent years, the best way is to wash the lungs. The effect can remove some inhaled aerosols, but the operation is complicated and not suitable for all silicosis patients.